• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有泌乳素瘤的女性在选择性经蝶窦腺瘤切除术后高泌乳素血症的复发情况。

Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma.

作者信息

Serri O, Rasio E, Beauregard H, Hardy J, Somma M

出版信息

N Engl J Med. 1983 Aug 4;309(5):280-3. doi: 10.1056/NEJM198308043090505.

DOI:10.1056/NEJM198308043090505
PMID:6866052
Abstract

To assess the long-term prognosis for women with prolactinoma after selective transsphenoidal adenomectomy, we followed 44 patients for 6.2 +/- 1.5 years. Group 1 (28 patients) had microprolactinomas, and Group 2 (16 patients) had macroprolactinomas. After surgery, normal plasma prolactin levels, resumption of menses, and cessation of galactorrhea were observed in 24 Group 1 patients (85 per cent) and 5 Group 2 patients (31 per cent). Hyperprolactinemia recurred in 12 of the 24 Group 1 patients and in 4 of the 5 Group 2 patients after 4 +/- 1.3 and 2.5 +/- 1.6 years of remission, respectively. There was no radiologic evidence of tumor recurrence in any patient, and no relation was found between the occurrence of pregnancy after surgery and the recurrence of hyperprolactinemia. Clinical and biologic features before surgery could not predict the long-term outcome. However, the immediate postoperative level of plasma prolactin was significantly lower in patients in whom normal prolactinemia (6.4 +/- 1.1 ng per milliliter) was maintained than in those who relapsed (11.7 +/- 1.5 ng per milliliter) (P less than 0.02). We conclude that recurrence of hyperprolactinemia after successful surgery is frequent but delayed. The immediate postoperative level of plasma prolactin may be a predictive risk factor.

摘要

为评估选择性经蝶窦腺瘤切除术后泌乳素瘤女性患者的长期预后,我们对44例患者进行了6.2±1.5年的随访。第1组(28例患者)为微泌乳素瘤,第2组(16例患者)为大泌乳素瘤。术后,第1组24例患者(85%)出现血浆泌乳素水平正常、月经恢复和溢乳停止,第2组5例患者(31%)出现上述情况。第1组24例患者中的12例以及第2组5例患者中的4例分别在缓解4±1.3年和2.5±1.6年后高泌乳素血症复发。所有患者均无肿瘤复发的影像学证据,且未发现术后妊娠与高泌乳素血症复发之间存在关联。术前的临床和生物学特征无法预测长期预后。然而,术后维持正常泌乳素血症(6.4±1.1 ng/ml)的患者术后即刻血浆泌乳素水平显著低于复发患者(11.7±1.5 ng/ml)(P<0.02)。我们得出结论,成功手术后高泌乳素血症复发很常见,但会延迟出现。术后即刻血浆泌乳素水平可能是一个预测风险因素。

相似文献

1
Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma.患有泌乳素瘤的女性在选择性经蝶窦腺瘤切除术后高泌乳素血症的复发情况。
N Engl J Med. 1983 Aug 4;309(5):280-3. doi: 10.1056/NEJM198308043090505.
2
Endocrine outcome after transsphenoidal adenomectomy for prolactinoma: prolactin levels and tumor size as predicting factors.经蝶窦垂体腺瘤切除术治疗泌乳素瘤后的内分泌结局:泌乳素水平和肿瘤大小作为预测因素
Surg Neurol. 1980 Aug;14(2):141-3.
3
Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.催乳素动态变化及肿瘤大小在泌乳素瘤手术预后预测中的作用
Q J Med. 1985 Feb;54(214):141-51.
4
Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.经蝶窦腺瘤切除术后分泌性垂体腺瘤的生化缓解及复发率:长期内分泌随访结果
Surg Neurol. 2007 Nov;68(5):513-8; discussion 518. doi: 10.1016/j.surneu.2007.05.057.
5
Transsphenoidal adenomectomy for microprolactinomas: 10 to 20 years of follow-up.经蝶窦腺瘤切除术治疗微泌乳素瘤:10至20年随访
Surg Neurol. 1996 Apr;45(4):341-6. doi: 10.1016/0090-3019(95)00430-0.
6
Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.库欣病治疗后获得性催乳素缺乏(APD)是不可逆性严重生长激素缺乏(GHD)的可靠标志物,但不能反映疾病状态。
Clin Endocrinol (Oxf). 2004 Apr;60(4):476-83. doi: 10.1111/j.1365-2265.2004.02004.x.
7
Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome.催乳素分泌型垂体腺瘤的外科治疗:早期结果与长期预后
J Clin Endocrinol Metab. 2002 Jul;87(7):3180-6. doi: 10.1210/jcem.87.7.8645.
8
[Hyperprolactinemia in patients with non-functioning adenoma: analysis of 85 patients treated by transsphenoidal operation].[无功能腺瘤患者的高催乳素血症:85例经蝶窦手术治疗患者的分析]
No Shinkei Geka. 1987 Nov;15(11):1175-9.
9
Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.接受手术治疗的泌乳素分泌型垂体瘤女性的长期随访
J Clin Endocrinol Metab. 1986 Jun;62(6):1296-301. doi: 10.1210/jcem-62-6-1296.
10
[Long-term surgical results of microprolactinomas].
No Shinkei Geka. 1991 Oct;19(10):951-6.

引用本文的文献

1
The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus.根据侵袭海绵窦程度对泌乳素瘤采用内镜经鼻蝶窦手术治疗的作用。
Pituitary. 2022 Jun;25(3):508-519. doi: 10.1007/s11102-022-01221-3. Epub 2022 Apr 25.
2
Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis.在内镜时代,多巴胺激动剂仍是催乳素瘤的首选治疗方法吗?一项系统评价和荟萃分析。
Chin Neurosurg J. 2022 Apr 8;8(1):9. doi: 10.1186/s41016-022-00277-1.
3
Magnetic resonance imaging in the management of prolactinomas; a review of the evidence.
磁共振成像在泌乳素瘤管理中的应用:证据回顾。
Pituitary. 2020 Feb;23(1):16-26. doi: 10.1007/s11102-019-01001-6.
4
Functioning Pituitary Adenomas - Current Treatment Options and Emerging Medical Therapies.功能性垂体腺瘤——当前的治疗选择与新兴药物疗法
Eur Endocrinol. 2019 Apr;15(1):30-40. doi: 10.17925/EE.2019.15.1.30. Epub 2019 Apr 12.
5
Bromocriptine therapy for the treatment of invasive prolactinoma: the single institute experience.溴隐亭治疗侵袭性泌乳素瘤:单机构经验
Brain Tumor Res Treat. 2013 Oct;1(2):71-7. doi: 10.14791/btrt.2013.1.2.71. Epub 2013 Oct 31.
6
Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors.催乳素瘤 erbB 受体表达和侵袭性肿瘤的靶向治疗。
Endocrine. 2014 Jun;46(2):318-27. doi: 10.1007/s12020-013-0093-x. Epub 2013 Nov 28.
7
Rapid reduction with cystic transformation of invasive giant prolactinoma following short term low dose cabergoline.短期低剂量卡麦角林治疗后侵袭性巨大泌乳素瘤快速缩小并发生囊性变
Indian J Endocrinol Metab. 2012 Nov;16(6):1048-51. doi: 10.4103/2230-8210.103041.
8
Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis.术后缓解后垂体腺瘤复发的临床相关因素:系统回顾和荟萃分析。
Pituitary. 2012 Mar;15(1):71-83. doi: 10.1007/s11102-011-0347-7.
9
Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists.对于小催乳素瘤,采用垂体手术代替多巴胺激动剂治疗。
Pituitary. 2011 Sep;14(3):222-30. doi: 10.1007/s11102-010-0283-y.
10
Efficacy and safety of cabergoline as first line treatment for invasive giant prolactinoma.卡麦角林作为一线治疗药物治疗侵袭性巨大泌乳素瘤的疗效和安全性。
J Korean Med Sci. 2009 Oct;24(5):874-8. doi: 10.3346/jkms.2009.24.5.874. Epub 2009 Sep 24.